Pearl Abyss stock surges as Crimson Desert release nears, targets 540 billion won revenue Pearl Abyss shares rally as ...

Jefferies highlights Bilibili's (BILI) focus on young users, AI-driven content, gaming longevity, and ad market gains.

Is This 1 Momentum Stock a Screaming Buy Right Now? For momentum investors, upward or downward trends in a stock's price or earnings outlook take precedent, so they'll want to zero in on the ...

Bilibili's valuation continues to be attractive and doesn't reflect current market consensus. Read why I'm upgrading my ...

Is This 1 Momentum Stock a Screaming Buy Right Now? Different than value or growth investors, momentum-oriented investors live by the saying "the trend is your friend." This investing style is all ...

Bilibili rallied for a second day on Monday, adding 7.66 percent to close at $22.48 apiece following news that it was set to ...

Fintel reports that on July 8, 2025, Bernstein initiated coverage of Bilibili (OTCPK:BLBLF) with a Outperform recommendation.

Fintel reports that on July 8, 2025, Bernstein initiated coverage of Bilibili Inc. - Depositary Receipt () (NasdaqGS:BILI) ...

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals' Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 ...

Find the latest Bilibili Inc. (9626.HK) stock quote, history, news and other vital information to help you with your stock trading and investing.